Drug Profile
K 777
Alternative Names: APC-3316; CRA-3316; K-777Latest Information Update: 28 Jul 2010
Price :
$50
*
At a glance
- Originator Celera Genomics Group; University of California at San Francisco
- Developer Institute for OneWorld Health; National Institutes of Health (USA)
- Class Amides; Antiprotozoals; Piperazines; Small molecules; Sulfones
- Mechanism of Action Cruzain inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chagas disease
Most Recent Events
- 03 Sep 2005 This compound is still in active development
- 27 Feb 2002 Preclinical trials in Chagas' disease in USA (PO,Tablet)